- Report
- August 2026
- 184 Pages
Global
From €3154EUR$3,545USD£2,708GBP
€3505EUR$3,939USD£3,009GBP
- Report
- August 2026
- 187 Pages
Global
From €3154EUR$3,545USD£2,708GBP
€3505EUR$3,939USD£3,009GBP
- Report
- January 2026
- 195 Pages
Global
From €3155EUR$3,545USD£2,708GBP
€3505EUR$3,939USD£3,009GBP
- Report
- August 2026
- 250 Pages
Global
From €3995EUR$4,490USD£3,430GBP
- Report
- February 2026
- 250 Pages
Global
From €3995EUR$4,490USD£3,430GBP
- Report
- February 2026
- 250 Pages
Global
From €3995EUR$4,490USD£3,430GBP
- Report
- February 2026
- 250 Pages
Global
From €3995EUR$4,490USD£3,430GBP
- Report
- February 2026
- 250 Pages
Global
From €3995EUR$4,490USD£3,430GBP
- Report
- February 2026
- 250 Pages
Global
From €3995EUR$4,490USD£3,430GBP
- Report
- February 2026
- 250 Pages
Global
From €3995EUR$4,490USD£3,430GBP
- Report
- February 2026
- 250 Pages
Global
From €3995EUR$4,490USD£3,430GBP
- Report
- February 2026
- 250 Pages
Global
From €3995EUR$4,490USD£3,430GBP
- Report
- February 2026
- 250 Pages
Global
From €3995EUR$4,490USD£3,430GBP
- Report
- February 2026
- 250 Pages
Global
From €3995EUR$4,490USD£3,430GBP
- Report
- February 2026
- 250 Pages
Global
From €3995EUR$4,490USD£3,430GBP
- Report
- July 2026
- 164 Pages
Global
From €7110EUR$7,990USD£6,103GBP
- Report
- July 2026
- 245 Pages
Global
From €7110EUR$7,990USD£6,103GBP
- Report
- July 2026
- 260 Pages
Global
From €7110EUR$7,990USD£6,103GBP
- Clinical Trials
- April 2026
- 280 Pages
Global
From €2670EUR$3,000USD£2,292GBP
- Report
- November 2025
- 200 Pages
Global
From €7074EUR$7,950USD£6,073GBP

Fluorouracil (5-FU) is a chemotherapy drug used in the treatment of cancer. It is a pyrimidine analog, which interferes with the synthesis of DNA and RNA, leading to cell death. It is used to treat a variety of cancers, including breast, colorectal, gastric, pancreatic, and head and neck cancers. It is also used in combination with other drugs to treat advanced or metastatic cancers. Fluorouracil is administered intravenously or topically, depending on the type of cancer being treated.
Fluorouracil is a widely used drug in the oncology market, and is often used in combination with other drugs to treat advanced or metastatic cancers. It is a generic drug, and is available in both branded and generic formulations. The branded formulations are typically more expensive than the generic versions.
Companies in the Fluorouracil market include Pfizer, Merck, Bristol-Myers Squibb, Teva Pharmaceuticals, Mylan, and Sandoz. Show Less Read more